BASEL, Switzerland, Aug. 11 -- PharmacoEconomics, a peer-reviewed journal that says it features application of pharmacoeconomics and quality-of-life assessment to optimum drug therapy and health outcomes, published research articles on the following topics in its Vol. 40, No. 9 edition:

Review Article:

* Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal